Date published: 2026-4-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

EP4 Inhibitors

EP4 inhibitors belong to a specific chemical class of compounds designed to target and modulate the activity of the EP4 receptor, a subtype of the prostaglandin E2 (PGE2) receptor family. These receptors play a pivotal role in the mediation of various physiological and pathological processes within the human body. EP4 inhibitors are characterized by their ability to selectively bind to and block the EP4 receptor, thereby interfering with the downstream signaling pathways initiated by PGE2 binding. This inhibition can have a profound impact on cellular and molecular responses in numerous tissues and organs. EP4 receptors are widely distributed throughout the body, with particularly high expression levels in the gastrointestinal tract, immune system, and the central nervous system. By targeting the EP4 receptor, inhibitors can influence a range of biological processes, including inflammation, pain perception, immune responses, and vasodilation. These compounds are designed to exert their effects by competitively binding to the EP4 receptor, preventing PGE2 from interacting with it. Consequently, the downstream signaling cascades mediated by the EP4 receptor, such as the activation of cyclic AMP (cAMP) and protein kinase A (PKA), are interrupted. The ultimate consequences of EP4 inhibition can vary depending on the specific biological context, but it often leads to a reduction in pro-inflammatory cytokine production, decreased pain sensitivity, and altered immune responses, making EP4 inhibitors an important tool for research.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

GW 627368X

439288-66-1sc-221702
sc-221702A
1 mg
5 mg
$96.00
$431.00
3
(1)

GW 627368X, acting as an EP4 agonist, demonstrates a distinctive affinity for the EP4 receptor, facilitating unique conformational changes that activate intracellular signaling cascades. Its molecular design allows for enhanced stability in aqueous environments, promoting effective receptor engagement. The compound exhibits a notable influence on the phosphorylation of downstream targets, thereby modulating cellular responses. Additionally, its interaction with membrane microdomains suggests a role in spatially organizing signaling complexes.

AH 23848 calcium salt

81496-19-7sc-221224
sc-221224A
1 mg
5 mg
$133.00
$604.00
2
(0)

AH 23848 calcium salt functions as an EP4 modulator, characterized by its selective binding to the EP4 receptor, which triggers specific allosteric changes in receptor conformation. This compound exhibits a unique kinetic profile, enhancing the rate of receptor activation and subsequent signal transduction. Its solubility properties facilitate effective interaction with lipid bilayers, potentially influencing membrane dynamics and receptor localization, thereby impacting downstream signaling pathways.

L-161,982

147776-06-5sc-203436
10 mg
$296.00
1
(0)

L-161,982 acts as a selective EP4 receptor antagonist, exhibiting unique molecular interactions that stabilize the inactive conformation of the receptor. This compound demonstrates distinct reaction kinetics, characterized by a rapid association and slower dissociation, which enhances its efficacy in modulating receptor activity. Its hydrophobic characteristics promote strong interactions with lipid environments, potentially altering membrane fluidity and influencing receptor clustering and downstream signaling cascades.

TCS 2510

346673-06-1sc-361377
1 mg
$217.00
2
(0)

CAY10598 is a research compound used in laboratory studies to investigate the role of EP4 receptors in various physiological processes.